zk 119010 has been researched along with Breast Cancer in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Knebel, NG; von Angerer, E | 1 |
Knuppen, R; Schneider, MR; Schütze, N; Vollmer, G | 1 |
2 other study(ies) available for zk 119010 and Breast Cancer
Article | Year |
---|---|
2-Phenylindole-linked [2-(aminoalkyl)pyridine]dichloroplatinum(II): complexes with a selective action on estrogen receptor positive mammary tumors.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cattle; Cell Line; Female; Humans; Mammary Neoplasms, Experimental; Mice; Organoplatinum Compounds; Receptors, Estrogen; Structure-Activity Relationship | 1991 |
Tamoxifen and ZK 119010 exert mixed agonistic and antagonistic effects on pS2 expression in MCF-7 cells.
Topics: Blotting, Northern; Breast Neoplasms; Estrogen Antagonists; Estrogens; Gene Expression Regulation, Neoplastic; Humans; Indoles; Neoplasm Proteins; Tamoxifen; Tumor Cells, Cultured | 1994 |